Pharmacoproteomics in the development of personalised medicine in Age-related Macular Degeneration (PHARPRO-AMD) study protocol.

Cañizo-Outeiriño A, Castro-Fernández DC, Arias-Barquet L, Fernández-Rodríguez MI, Olivier-Pascual N, Ortea I, Pastor-Iodate S, Rodríguez-De la Rúa-Franch E, Ruiz-Moreno JM, Ruiz-Moreno Ó, Sáenz de Viteri-Vázquez M, Sala-Puigdollers A, PHARPRO-AMD Study Group, Fernández-Ferreiro A.

Open source

DOI: 10.1136/bmjophth-2024-001956
Published: 2025-08-24
Container: BMJ Open Ophthalmol
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjophth-2024-001956,
  title = {Pharmacoproteomics in the development of personalised medicine in Age-related Macular Degeneration (PHARPRO-AMD) study protocol.},
  author = {Cañizo-Outeiriño A and  Castro-Fernández DC and  Arias-Barquet L and  Fernández-Rodríguez MI and  Olivier-Pascual N and  Ortea I and  Pastor-Iodate S and  Rodríguez-De la Rúa-Franch E and  Ruiz-Moreno JM and  Ruiz-Moreno Ó and  Sáenz de Viteri-Vázquez M and  Sala-Puigdollers A and  PHARPRO-AMD Study Group and  Fernández-Ferreiro A.},
  year = {2025},
  journal = {BMJ Open Ophthalmol},
  doi = {10.1136/bmjophth-2024-001956},
  url = {https://doi.org/10.1136/bmjophth-2024-001956}
}

RIS

TY  - JOUR
TI  - Pharmacoproteomics in the development of personalised medicine in Age-related Macular Degeneration (PHARPRO-AMD) study protocol.
AU  - Cañizo-Outeiriño A
AU  -  Castro-Fernández DC
AU  -  Arias-Barquet L
AU  -  Fernández-Rodríguez MI
AU  -  Olivier-Pascual N
AU  -  Ortea I
AU  -  Pastor-Iodate S
AU  -  Rodríguez-De la Rúa-Franch E
AU  -  Ruiz-Moreno JM
AU  -  Ruiz-Moreno Ó
AU  -  Sáenz de Viteri-Vázquez M
AU  -  Sala-Puigdollers A
AU  -  PHARPRO-AMD Study Group
AU  -  Fernández-Ferreiro A.
PY  - 2025
JO  - BMJ Open Ophthalmol
DO  - 10.1136/bmjophth-2024-001956
UR  - https://doi.org/10.1136/bmjophth-2024-001956
ER  -

APA

A, C., DC, C., L, A., MI, F., N, O., I, O., S, P., E, R. L. R., JM, R., Ó, R., M, S. D. V., A, S., Group, P. S., & A., F. (2025). Pharmacoproteomics in the development of personalised medicine in Age-related Macular Degeneration (PHARPRO-AMD) study protocol.. BMJ Open Ophthalmol. https://doi.org/10.1136/bmjophth-2024-001956

Source records

europe-pmc · retrieved 2026-09-27T02:23:00.637Z
doaj · retrieved 2026-09-27T02:23:00.641Z